3 July 2018 - The Biosafety Advisory Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
A Phase I/IIa study of TG6002 (VV TK-RR-FCU1) administered by intravenous (IV) infusions in combination with oral flucytosine (5-FC) in patients with advanced gastro-intestinal (GI) tumors